Skip to main content

Table 5 Hematologic indices of systemic inflammation according to different disability level groups

From: Effects of physical activity levels on characteristic pain in temporomandibular dysfunctions: a cross-sectional study

 

Low (n = 77)

High (n = 22)

P-value

WBC†

5.83 (1.42)

6.02 (1.39)

0.584

WBC group (≥ 10)‡‡

1.30% (1/77)

0.00% (0/22)

1.000

RBC†

4.51 (0.37)

4.43 (0.34)

0.355

RBC group (≥ 5.40)‡‡

6.49% (5/77)

9.09% (2/22)

0.650

Hgb††

13.70 (12.80, 14.30)

13.60 (12.65, 14.05)

0.426

Hgb group (< 12)‡‡

2.60% (2/77)

4.55% (1/22)

0.534

Hct†

40.71 (3.11)

39.96 (2.74)

0.315

Hct group (≤ 36)‡‡

3.90% (3/77)

9.09% (2/22)

0.307

Platelet†

262.90 (47.60)

269.32 (51.68)

0.589

PLR††

82.87 (30.38)

86.88 (32.68)

0.749

PLR group (≥ 142.76 (F), ≥ 122.73 (M))‡‡

3.90% (3/77)

4.55% (1/22)

1.000

NLR††

1.13 (0.76)

1.25 (0.83)

0.614

NLR group (≥ 1.662 (F), ≥ 1.634 (M))‡‡

15.58% (12/77)

27.27% (6/22)

0.222

dNLR†

1.40 (0.53)

1.47 (0.62)

0.601

LMR††

5.10 (3.93, 6.26)

4.83 (3.84, 5.68)

0.711

LMR group (≤ 5.598 (F), ≤ 5.048 (M))‡

33.77% (26/77)

31.82% (7/22)

1.000

SII††

249.58 (171.78, 356.45)

255.39 (181.97, 399.05)

0.668

ESR (mm/h)††

5.00 (2.00, 10.00)

9.00 (4.25, 14.75)

0.440

CRP (mg/L)††

0.04 (0.02, 0.08)

0.05 (0.04, 0.08)

0.354

RF‡‡

1.30% (1/76)

4.50% (1/22)

0.400

FANA‡

29.90% (23/77)

18.20% (4/22)

0.416

Anti-CCP‡‡

3.90% (3/77)

0.00% (0/22)

1.000

Total protein (g/dL)††

7.40 (7.1, 7.7)

7.30 (7.0, 7.58)

0.660

  1. WBC: White blood cell, RBC: Red blood cell, Hgb: Hemoglobin, Hct: Hematocrit, PLR: Platelet-to-lymphocyte ratio, NLR: Neutrophil-lymphocyte ratio, dNLR: derived neutrophil-lymphocyte ratio, LMR: Lymphocyte-monocyte ratio, SII: Systemic inflammatory index, ESR: Erythrocyte sedimentation rate, CRP: C-reactive protein, RF: Rheumatoid factor, FANA: Fluorescent antinuclear antibody, anti-CCP: anti-cyclic citrullinated peptide
  2. †Differences between groups were tested with independent t-test: mean (standard deviation)
  3. ††Differences between groups were tested with Mann-Whitney test: median (lower quartile, upper quartile)
  4. ‡Differences between groups were tested with chi-square test: number of subjects or positive palpation sites (%)
  5. ‡‡Differences between groups were tested with Fisher’s exact test: number of subjects or positive palpation sites (%)
  6. *Significant difference, p < 0.05
Back to article page

Head & Face Medicine

ISSN: 1746-160X

Contact us